SPECT/CT imaging of 177Lu-labeled phosphoramidate-based PSMA inhibitor with an albumin-binding motif

被引：0

作者：

Ling, Xiaoxi ^{[1
]}

Choy, Cindy ^{[2
]}

Latoche, Joseph ^{[1
]}

Geruntho, Jonathan ^{[1
]}

Wu, Yijen ^{[3
,4
]}

Salamacha, Nathan ^{[3
,4
]}

Langton-Webster, Beatrice ^{[2
]}

Anderson, Carolyn ^{[1
,5
]}

Berkman, Clifford ^{[2
]}

机构：

[1] Univ Pittsburgh, Dept Med, Pittsburgh, PA USA

[2] Canc Targeted Technol, Woodinville, WA USA

[3] UPMC, Childrens Hosp Pittsburgh, Rangos Res Ctr Anim Imaging Core, Pittsburgh, PA USA

[4] Univ Pittsburgh, Dept Dev Biol, Pittsburgh, PA USA

[5] Univ Pittsburgh, Dept Radiol, Pittsburgh, PA 15260 USA

来源：

ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY | 2018年 / 255卷

关键词：

D O I：

暂无

中图分类号：

O6 [化学];

学科分类号：

0703 ;

摘要：

引用

页数：2

共 50 条

[1] Improving the in vitro and in vivo performance of a 177Lu-labeled phosphoramidate-based PSMA inhibitor with an albumin-binding motif
Choy, Cindy
Ling, Xiaoxi
Geruntho, Jonathan
Beyers, Sophia
Latoche, Joseph
Langton-Webster, Beatrice
Anderson, Carolyn
Berkman, Clifford
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2017, 253
[2] Comparison of traditional and albumin-binding Lu-177-labeled phosphoramidate-based PSMA inhibitors for targeted radionuclide therapy of prostate cancer
Ling, Xiaoxi
Choy, Cindy
Geruntho, Jonathan
Beyer, Sophia
Latoche, Joseph
Langton-Webster, Beatrice
Anderson, Carolyn
Berkman, Clifford
JOURNAL OF NUCLEAR MEDICINE, 2017, 58
[3] 177Lu-Labeled Phosphoramidate-Based PSMA Inhibitors: The Effect of an Albumin Binder on Biodistribution and Therapeutic Efficacy in Prostate Tumor-Bearing Mice
Choy, Cindy J.
Ling, Xiaoxi
Geruntho, Jonathan J.
Beyer, Sophia K.
Latoche, Joseph D.
Langton-Webster, Beatrice
Anderson, Carolyn J.
Berkman, Clifford E.
THERANOSTICS, 2017, 7 (07): : 1928 - 1939
[4] Preclinical Evaluation of a New Series of Albumin-Binding 177Lu-Labeled PSMA-Based Low-Molecular-Weight Radiotherapeutics
Boinapally, Srikanth
Alati, Suresh
Jiang, Zirui
Yan, Yu
Lisok, Alla
Singh, Rajan
Lofland, Gabriela
Minn, Il
Hobbs, Robert F.
Pomper, Martin G.
Banerjee, Sangeeta Ray
MOLECULES, 2023, 28 (16):
[5] Evaluation of the effect of the addition of an albumin-binding motif on 177Lu-DOTATATE
Rousseau, Etienne
Lau, Joseph
Zhang, Zhengxing
Uribes, Carlos
Kuo, Hsiou-Ting
Zeisler, Jutta
Colpo, Nadine
Lin, Kuo-Shyan
Benard, Francois
JOURNAL OF NUCLEAR MEDICINE, 2018, 59
[6] Enhancing Treatment Efficacy of 177Lu-PSMA-617 with the Conjugation of an Albumin-Binding Motif: Preclinical Dosimetry and Endoradiotherapy Studies
Kuo, Hsiou-Ting
Merkens, Helen
Zhang, Zhengxing
Uribe, Carlos F.
Lau, Joseph
Zhang, Chengcheng
Colpo, Nadine
Lin, Kuo-Shyan
Benard, Francois
MOLECULAR PHARMACEUTICS, 2018, 15 (11) : 5183 - 5191
[7] Whole Body and SPECT/CT Imaging for Dosimetry of 177Lu-labeled Radiopharmaceutical Therapies: A Technologist's Perspective
Jung, Natalie
Aga, Natasha
Minh Lu
Uribe, Carlos
Colpo, Nadine
JOURNAL OF NUCLEAR MEDICINE, 2022, 63
[8] Enhancing treatment efficacy of 177Lu-PSMA-617 with the conjugation of an albumin-binding motif: preclinical dosimetry and endoradiotherapy studies
Kuo, H.
Merkens, H.
Zhang, Z.
Uribe, C.
Zhang, C.
Lau, J.
Colpo, N.
Benard, F.
Lin, K.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2018, 45 : S53 - S53
[9] Preclinical Dosimetry, Imaging, and Targeted Radionuclide Therapy Studies of Lu-177-Labeled Albumin-Binding, PSMA-Targeted CTT1403
Ling, Xiaoxi
Latoche, Joseph D.
Choy, Cindy J.
Kurland, Brenda F.
Laymon, Charles M.
Wu, Yijen
Salamacha, Nathan
Shen, Ding
Geruntho, Jonathan J.
Rigatti, Lora H.
Windish, Hillarie P.
Langton-Webster, Beatrice
Berkman, Clifford E.
Anderson, Carolyn J.
MOLECULAR IMAGING AND BIOLOGY, 2020, 22 (02) : 274 - 284
[10] Prospects of medium specific activity 177Lu in targeted therapy of prostate cancer using 177Lu-labeled PSMA inhibitor
Chakraborty, Sudipta
Chakravarty, Rubel
Shetty, Priyalata
Vimalnath, K. V.
Sen, Ishita B.
Dash, Ashutosh
JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS, 2016, 59 (09): : 364 - 371

← 1 2 3 4 5 →